FDA Submission for Finerenone by Macleods Pharmaceuticals
Macleods Pharmaceuticals has submitted an ANDA for Finerenone, currently under review.
Therapeutic Area
Therapeutic area intelligence for Mineralocorticoid Receptor Antagonist with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.